← Evidence map

RetractedArticleScience translational medicine2021

Targeted immunotherapy for HER2-low breast cancer with 17p loss.

Yujing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33568521